HUP9602254A3 - New cephalosporins containing in position 7 a substituted benzyloxyimino radical, their preparation process and intermediates, their use as medicaments - Google Patents

New cephalosporins containing in position 7 a substituted benzyloxyimino radical, their preparation process and intermediates, their use as medicaments

Info

Publication number
HUP9602254A3
HUP9602254A3 HU9602254A HUP9602254A HUP9602254A3 HU P9602254 A3 HUP9602254 A3 HU P9602254A3 HU 9602254 A HU9602254 A HU 9602254A HU P9602254 A HUP9602254 A HU P9602254A HU P9602254 A3 HUP9602254 A3 HU P9602254A3
Authority
HU
Hungary
Prior art keywords
medicaments
intermediates
preparation process
new cephalosporins
radical
Prior art date
Application number
HU9602254A
Other languages
English (en)
Original Assignee
Hoechst Marion Roussel Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel Inc filed Critical Hoechst Marion Roussel Inc
Publication of HU9602254D0 publication Critical patent/HU9602254D0/hu
Publication of HUP9602254A2 publication Critical patent/HUP9602254A2/hu
Publication of HUP9602254A3 publication Critical patent/HUP9602254A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C239/00—Compounds containing nitrogen-to-halogen bonds; Hydroxylamino compounds or ethers or esters thereof
    • C07C239/08—Hydroxylamino compounds or their ethers or esters
    • C07C239/20—Hydroxylamino compounds or their ethers or esters having oxygen atoms of hydroxylamino groups etherified
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/587—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with aliphatic hydrocarbon radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms, said aliphatic radicals being substituted in the alpha-position to the ring by a hetero atom, e.g. with m >= 0, Z being a singly or a doubly bound hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
HU9602254A 1995-08-16 1996-08-15 New cephalosporins containing in position 7 a substituted benzyloxyimino radical, their preparation process and intermediates, their use as medicaments HUP9602254A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9509822A FR2737893B1 (fr) 1995-08-16 1995-08-16 Nouvelles cephalosporines comportant en position 7, un radical benzyloxyimino substitue, leur procede et intermediaires de preparation, leur application comme medicaments

Publications (3)

Publication Number Publication Date
HU9602254D0 HU9602254D0 (en) 1996-10-28
HUP9602254A2 HUP9602254A2 (en) 1997-05-28
HUP9602254A3 true HUP9602254A3 (en) 2001-04-28

Family

ID=9481928

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9602254A HUP9602254A3 (en) 1995-08-16 1996-08-15 New cephalosporins containing in position 7 a substituted benzyloxyimino radical, their preparation process and intermediates, their use as medicaments

Country Status (15)

Country Link
EP (1) EP0761672B1 (hu)
JP (1) JPH0959281A (hu)
KR (1) KR970010775A (hu)
CN (2) CN1152575A (hu)
AT (1) ATE208396T1 (hu)
AU (1) AU708973B2 (hu)
CA (1) CA2183469A1 (hu)
DE (1) DE69616702T2 (hu)
DK (1) DK0761672T3 (hu)
EA (1) EA000165B1 (hu)
ES (1) ES2164853T3 (hu)
FR (1) FR2737893B1 (hu)
HU (1) HUP9602254A3 (hu)
PT (1) PT761672E (hu)
ZA (1) ZA966465B (hu)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR029876A1 (es) * 1998-05-11 2003-07-23 Takeda Pharmaceutical Compuesto de acido oxiiminoalcanoilo, composicion farmaceutica y agente para controlar receptores relacionados con retinoide que lo comprenden y su uso

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2684995A1 (en) * 1991-12-12 1993-06-18 Roussel Uclaf Cephalosporins containing a ( alpha -carboxy-3,4-dihydroxybenzyloxyimino) group, preparation process and intermediates, application as medicaments and pharmaceutical compositions
FR2663332B1 (fr) * 1990-06-15 1997-11-07 Roussel Uclaf Nouvelles cephalosporines comportant en position 3 un radical propenyle substitue par un ammonium quaternaire, leur procede de preparation, leur application comme medicaments, les compositions les renfermant et les nouveaux intermediaires obtenus.
HU221478B (en) * 1991-12-12 2002-10-28 Hoechst Marion Roussel Inc Cephalosporine derivatives substituted in 7th position by benzyl-oxi-imino group, pharmaceutical compositions containing the same, method for producing them and intermediates
KR100257130B1 (ko) * 1993-09-11 2000-05-15 성재갑 신규 세팔로스포린계 항생제 및 이의 제조방법

Also Published As

Publication number Publication date
CN1388120A (zh) 2003-01-01
ZA966465B (en) 1997-07-30
CN1152575A (zh) 1997-06-25
DE69616702D1 (de) 2001-12-13
JPH0959281A (ja) 1997-03-04
AU6209896A (en) 1997-02-20
ATE208396T1 (de) 2001-11-15
DK0761672T3 (da) 2002-03-11
FR2737893B1 (fr) 1997-09-12
CA2183469A1 (fr) 1997-02-17
EA000165B1 (ru) 1998-10-29
EA199600055A1 (ru) 1997-03-31
EP0761672A1 (fr) 1997-03-12
FR2737893A1 (fr) 1997-02-21
DE69616702T2 (de) 2002-08-01
EP0761672B1 (fr) 2001-11-07
KR970010775A (ko) 1997-03-27
PT761672E (pt) 2002-04-29
HU9602254D0 (en) 1996-10-28
HUP9602254A2 (en) 1997-05-28
AU708973B2 (en) 1999-08-19
ES2164853T3 (es) 2002-03-01

Similar Documents

Publication Publication Date Title
EG23763A (en) Novel pharmaceutical product
HK1041489A1 (en) 5-0-Desosaminyl 6-0-methylerythronolide a for use for the preparation of bilogically-active products
ZA957753B (en) Novel pharmaceutical product
NZ239513A (en) Interleukin-2-leukotoxin gene fusion product, it's production and use
HUP9903733A3 (en) New phenylamidine derivatives, a process for preparing the same and their use as medicaments
AU639825B2 (en) Substituted 1,2,4-triazinediones, processes for their preparation, intermediates therefor and their use
AU7719791A (en) Therapeutic product
HU9303540D0 (en) New cephalosporins containing a substituted oximino radical in position 7, their preparation process and intermediates and their use as medicaments
AU4172693A (en) Novel thienothiazine derivatives, process for their preparation and their use
HU9502158D0 (en) New cephalosporins containing in position 7 a substituted benzyloxyimino radical, their preparation process, their use as medicaments
HUP9602254A3 (en) New cephalosporins containing in position 7 a substituted benzyloxyimino radical, their preparation process and intermediates, their use as medicaments
AU4458489A (en) 1-aminoalkyl-3-oxysubstituted-4-aryl-1,3,4,5-tetrahydro-2h- 1,3-benzodiazepine-2-ones, a process for their preparation and their use as medicaments
ZA929626B (en) Cephalosporins containing in position 7 a substituted benzyloxyimino radical, their preparation process and their use as medicaments
AU664058C (en) New cephalosporins containing in position 7 a substituted benzyloxyimino radical, their preparation process and their use as medicaments
AU126984S (en) Pharmaceutical product
AU3885995A (en) Novel medicinal use
AU2272788A (en) 2,6-methanopyrrolo-3-benzazocines, a process and intermediates for their preparation and their use as medicaments
PL303311A1 (en) Chese-maker's product
IL129802A0 (en) Novel 5'-hydroxybutyrolactam derivatives and a process for their preparation
HU9700366D0 (en) Novel derivatives of 3-bromo- and 3,3 dibromo-4-oxo-1-azetidines, process for the preparation thereof and their use
IL129830A0 (en) 2,2-difluoroketensilyl o,s-acetal derivatives and a process for their preparation
GB2273096B (en) Piperido (4',3':16,17)-4-Aza-5alpha-androstan-3-one derivatives and process for their preparation
GB9314488D0 (en) 2,2'-dipyrromethene derivatives and process for their preparation
GB9507433D0 (en) New compounds FR 182876 and FR 182877,production thereof and use thereof
HU9503344D0 (en) New compounds of the secomacrolide and secoazalide class and a process eor the preparation thereof